Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hikaru Miyamoto is active.

Publication


Featured researches published by Hikaru Miyamoto.


Thoracic Cancer | 2018

Platelet‐to‐lymphocyte ratio predicts the prognosis of patients with non‐small cell lung cancer treated with surgery and postoperative adjuvant chemotherapy

Michihito Toda; Takuma Tsukioka; Nobuhiro Izumi; Hiroaki Komatsu; Satoshi Okada; Kantaro Hara; Hikaru Miyamoto; Ryuichi Ito; Toshihiko Shibata; Noritoshi Nishiyama

Markers of preoperative tumor immunity, such as platelet‐to‐lymphocyte ratio (PLR), have been reported to be prognostic factors for patients with various cancers. However, the relationship between PLR and the prognosis of non‐small cell lung cancer (NSCLC) patients treated with surgery and adjuvant chemotherapy as a multidisciplinary treatment is unknown.


The Japanese Journal of Thoracic and Cardiovascular Surgery | 2018

Positive correlation between sarcopenia and elevation of neutrophil/lymphocyte ration in pathological stage IIIA (N2-positive) non-small cell lung cancer patients

Takuma Tsukioka; Nobuhiro Izumi; Shinjiro Mizuguchi; Chung Kyukwang; Hiroaki Komatsu; Michihito Toda; Kantaro Hara; Hikaru Miyamoto; Noritoshi Nishiyama

ObjectiveSurgical indication in stage IIIA (N2) non-small cell lung cancer is still controversial. Hence, there is a need for the identification of predictors of the postoperative outcome in these patients. Although sarcopenia is expected to be a novel predictor of postoperative outcome in these patients, the underlying clinical features of sarcopenia have not been well investigated. Elevation of neutrophil/lymphocyte ratio indicates cancer-associated inflammation and depression of anticancer immunity. We analyzed the influence of sarcopenia on postoperative prognosis, and investigated the relationship between sarcopenia and neutrophil/lymphocyte ratio in patients with stage IIIA (N2) non-small cell lung cancer.MethodsWe retrospectively investigated 69 patients with stage IIIA (N2) non-small cell lung cancer. We used the L3 muscle index as a clinical measurement of sarcopenia, and divided patients into the sarcopenic (n = 21) and the non-sarcopenic group (n = 48). We then investigated the effect of sarcopenia on postoperative prognosis, and evaluated the correlation between sarcopenia and neutrophil/lymphocyte ratio.ResultsThis study included 47 males and 22 females. Univariate analysis revealed that sarcopenia, performance status, and serum cytokeratin-19 fragment level were predictors of poor prognosis; multivariate analysis revealed that performance status and sarcopenia were independent predictors of poor prognosis. The presence of sarcopenia was significantly correlated with neutrophil/lymphocyte ratio elevation.ConclusionsSarcopenia is a novel predictor of poor prognosis in patients with stage IIIA (N2) non-small cell lung cancer. Neutrophil/lymphocyte ratio elevation might be the reason for poor prognosis in sarcopenic patients.


Open Journal of Thoracic Surgery | 2018

Relationship between Perioperative N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Complications in Thoracic Surgery

Kantaro Hara; Takuma Tsukioka; Nobuhiro Izumi; Kyukwang Chung; Hiroaki Komatsu; Michihito Toda; Hikaru Miyamoto; Satoshi Suzuki; Takuya Kimura; Toshihiko Shibata; Noritoshi Nishiyama

Background: In cardiac surgery, the N-terminal pro-brain natriuretic peptide (NT-proBNP) level is reportedly correlated with the onset of postoperative complications. We examined the relationship between the NT-proBNP level and perioperative complications in thoracic surgery and elucidated the significance of NT-proBNP measurement. Methods: We evaluated 48 patients excluding hemodialysis patients who underwent lung resection from November 2015 to February 2016. NT-proBNP measurement was performed three times preoperatively on postoperative days 2 and 5. We examined the relationship between clinical background factors such as preoperative comorbidity and the development of postoperative complications. Based on established criteria for surgical complications (Clavien-Dindo classification), grade ≥ II was defined as a complications. We classified the patients into two groups (with or without complications) and compared and examined the background factors between the groups. Results: The study included 48 patients (33 male, 15 female) with an average age of 72 years (range, 35 - 86 years). Preoperative comorbidities included cardiovascular disease in five patients, diabetes mellitus in four, and chronic obstructive pulmonary disease in six. The average operation time was 163 (29 - 308) minutes, and the bleeding volume was 30 (10 - 620) ml. Early complications were confirmed in 11 patients, and late complications were confirmed in 7 patients. A high NT-proBNP level on postoperative day 5 was an independent risk factor for late complications. Conclusion: The perioperative NT-proBNP level is considered to be a predictor of complications. Its measurement is useful for predicting postoperative complications, and careful perioperative management is required for patients with high levels.


Thoracic Cancer | 2017

Solitary splenic metastasis from lung adenocarcinoma: A case report

Kantaro Hara; Nobuhiro Izumi; Takuma Tsukioka; Hiroaki Komatsu; Michihito Toda; Hikaru Miyamoto; Satoshi Suzuki; Takuya Kimura; Toshihiko Shibata; Noritoshi Nishiyama

Solitary splenic metastasis is extremely rare, with only 27 reported cases in the literature. An 81‐year‐old woman was referred to our hospital for treatment of pulmonary and splenic lesions. Chest computed tomography showed a small lung nodule in the right upper lobe, abdominal computed tomography showed an 8 cm splenic mass with abnormal accumulation, and positron emission tomography revealed a maximum standardized uptake value of 7.9. She had elevated serum cancer antigen 19‐9 (1847 U/mL) and carcinoembryonic antigen concentrations (17.9 ng/mL). She underwent laparoscopic splenectomy. Pathological examination revealed poorly differentiated adenocarcinoma. We performed partial lung resection and diagnosed the small lung lesion as lung adenocarcinoma. Both lesions were positive for thyroid transcription factor 1. Thus, primary lung adenocarcinoma and solitary splenic metastasis were diagnosed. The patient was still alive without recurrence four years postoperatively. Herein, we report a rare case of lung adenocarcinoma with solitary splenic metastasis and review the literature.


Annals of Thoracic and Cardiovascular Surgery | 2017

Elevation of Serum Carcinoembryonic Antigen Concentration Caused by Everolimus-Induced Lung Injury: A Case Report

Hiroaki Komatsu; Nobuhiro Izumi; Takuma Tsukioka; Michihito Toda; Kantaro Hara; Hikaru Miyamoto; Noritoshi Nishiyama

A 66-year-old woman underwent right nephrectomy for treatment of renal cell carcinoma (RCC). Two years later, she underwent wedge resection of the right lung for treatment of metastatic RCC and primary adenocarcinoma of the lung. She began oral sorafenib for the remaining nodules of the left lung, which were suspected to be metastatic RCC. Two years later, the sorafenib was changed to everolimus because of slight enlargement of the left pulmonary nodules. The carcinoembryonic antigen (CEA) concentration then increased to 25.7 ng/mL, and chest computed tomography (CT) revealed ground-glass opacities (GGO) in the bilateral lungs. Everolimus-induced lung injury was suspected, and she discontinued the everolimus. Two months later, the serum CEA concentration decreased to almost within the reference range at 5.9 ng/mL, and the GGO disappeared on chest CT. In conclusion, we encountered a patient who developed an elevated serum CEA concentration caused by everolimus-induced lung injury.


Esophagus | 2015

Cytomegalovirus-associated ulceration of gastric conduit after chemoradiotherapy following esophagectomy for cancer

Yasunori Matsuda; Satoru Kishida; Hikaru Miyamoto; Shigeru Lee; Masato Okawa; Yushi Fujiwara; Ryoya Hashiba; Eijiro Edagawa; Sayaka Tanaka; Masahiko Osawa; Harushi Osugi

A 64-year-old man underwent radical esophagectomy for cancer and simultaneous reconstruction using the gastric conduit through the posterior mediastinum. Two courses of adjuvant chemotherapy were performed. Twenty-eight months postoperatively, recurrence of the cancer was detected in the mediastinal lymph nodes, and he underwent concurrent chemoradiotherapy and boost chemotherapy. Endoscopy was then performed to investigate the cause of epigastralgia, and multiple ulcerations were found in the lesser curvature of the gastric conduit. Although a proton-pump inhibitor was orally administered, the ulceration was intractable. Re-examination of the original biopsy specimens and serological testing revealed positivity for cytomegalovirus. The ulcers began to heal after administration of foscarnet sodium. After the treatment, no signs of exacerbation associated with reinstitution of chemotherapy were observed.


The Japanese Journal of Thoracic and Cardiovascular Surgery | 2018

Thoracoscopic resection of mediastinal tumor in a patient with azygos continuation of the inferior vena cava

Hiroaki Komatsu; Nobuhiro Izumi; Takuma Tsukioka; Hidetoshi Inoue; Kantaro Hara; Hikaru Miyamoto; Noritoshi Nishiyama


International Journal of Clinical Oncology | 2018

Impact of multiple malignancies on surgical outcomes in patients with 1 cm or smaller non-small cell lung cancer

Takuma Tsukioka; Nobuhiro Izumi; Shinjiro Mizuguchi; Chung Kyukwang; Hiroaki Komatsu; Michihito Toda; Kantaro Hara; Hikaru Miyamoto; Noritoshi Nishiyama


Free Radical Biology and Medicine | 2018

Effects of pirfenidone on rat alveolar macrophage skewing and macrophage-fibroblast interactions

Hikaru Miyamoto; Takuma Tsukioka; Shinjiro Mizuguchi; Yukiko Minamiyama; Shigekazu Takemura; Michihito Toda; Noritoshi Nishiyama


Free Radical Biology and Medicine | 2018

Suppressive effects on lung fibrosis and the polarization and populations of macrophages by liposomal clodronate combined with pirfenidone

Michihito Toda; Shinjiro Mizuguchi; Yukiko Minamiyama; Shigekazu Takemura; Hiroko Oka-Yamamoto; Takanori Aota; Hikaru Miyamoto; Noritoshi Nishiyama

Collaboration


Dive into the Hikaru Miyamoto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge